Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.

Forensic Sci Int. 2017 Aug 26;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. [Epub ahead of print]

PMID:
28869822
2.

Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.

Müller S, Preische O, Göpfert JC, Yañez VAC, Joos TO, Boecker H, Düzel E, Falkai P, Priller J, Buerger K, Catak C, Janowitz D, Heneka MT, Brosseron F, Nestor P, Peters O, Menne F, Schipke CG, Schneider A, Spottke A, Fließbach K, Kilimann I, Teipel S, Wagner M, Wiltfang J, Jessen F, Laske C.

Sci Rep. 2017 Aug 25;7(1):9529. doi: 10.1038/s41598-017-08779-0.

3.

Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients-Comparison between single and chronic GHB exposure.

Mehling LM, Wang X, Johansen SS, Spottke A, Heidbreder A, Young P, Madea B, Hess C.

Forensic Sci Int. 2017 Sep;278:e8-e13. doi: 10.1016/j.forsciint.2017.07.027. Epub 2017 Jul 31.

PMID:
28811136
4.

Alterations in gene expression after gamma-hydroxybutyric acid intake-A pilot study.

Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Courts C.

Int J Legal Med. 2017 May 22. doi: 10.1007/s00414-017-1609-3. [Epub ahead of print]

PMID:
28534145
5.

Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease.

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.

Int J Methods Psychiatr Res. 2017 Apr 18. doi: 10.1002/mpr.1564. [Epub ahead of print]

PMID:
28418163
6.

Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia.

Teipel S, Raiser T, Riedl L, Riederer I, Schroeter ML, Bisenius S, Schneider A, Kornhuber J, Fliessbach K, Spottke A, Grothe MJ, Prudlo J, Kassubek J, Ludolph A, Landwehrmeyer B, Straub S, Otto M, Danek A; FTLDc study group.

Cortex. 2016 Oct;83:124-35. doi: 10.1016/j.cortex.2016.07.004. Epub 2016 Jul 16.

7.

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R.

J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1099-105. doi: 10.1136/jnnp-2016-313838. Epub 2016 Jul 8.

PMID:
27401782
8.

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.

Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R.

Parkinsonism Relat Disord. 2016 Aug;29:112-6. doi: 10.1016/j.parkreldis.2016.04.013. Epub 2016 Apr 19.

PMID:
27321987
9.

The association between alterations of eye movement control and cerebral intrinsic functional connectivity in Parkinson's disease.

Gorges M, Müller HP, Lulé D; LANDSCAPE Consortium, Pinkhardt EH, Ludolph AC, Kassubek J.

Brain Imaging Behav. 2016 Mar;10(1):79-91. doi: 10.1007/s11682-015-9367-7.

PMID:
25749936
10.

Cortical thinning in individuals with subjective memory impairment.

Meiberth D, Scheef L, Wolfsgruber S, Boecker H, Block W, Träber F, Erk S, Heneka MT, Jacobi H, Spottke A, Walter H, Wagner M, Hu X, Jessen F.

J Alzheimers Dis. 2015;45(1):139-46. doi: 10.3233/JAD-142322.

PMID:
25471190
11.

Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment.

Scheef L, Spottke A, Daerr M, Joe A, Striepens N, Kölsch H, Popp J, Daamen M, Gorris D, Heneka MT, Boecker H, Biersack HJ, Maier W, Schild HH, Wagner M, Jessen F.

Neurology. 2012 Sep 25;79(13):1332-9. Epub 2012 Aug 22.

PMID:
22914828
12.

Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease.

Bach JP, Riedel O, Klotsche J, Spottke A, Dodel R, Wittchen HU.

J Neurol Sci. 2012 Mar 15;314(1-2):41-7. doi: 10.1016/j.jns.2011.11.002. Epub 2011 Nov 30.

PMID:
22133477
13.

Parkinson's disease and dementia: a longitudinal study (DEMPARK).

Balzer-Geldsetzer M, Costa AS, Kronenbürger M, Schulz JB, Röske S, Spottke A, Wüllner U, Klockgether T, Storch A, Schneider C, Riedel O, Wittchen HU, Seifried C, Hilker R, Schmidt N, Witt K, Deuschl G, Mollenhauer B, Trenkwalder C, Liepelt-Scarfone I, Gräber-Sultan S, Berg D, Gasser T, Kalbe E, Bodden M, Oertel WH, Dodel R.

Neuroepidemiology. 2011;37(3-4):168-76. doi: 10.1159/000331490. Epub 2011 Nov 4.

PMID:
22067139
14.

Evidence of neuronal compensation during episodic memory in subjective memory impairment.

Erk S, Spottke A, Meisen A, Wagner M, Walter H, Jessen F.

Arch Gen Psychiatry. 2011 Aug;68(8):845-52. doi: 10.1001/archgenpsychiatry.2011.80.

PMID:
21810648
15.

[Benchmarking in patient care: depression in Parkinson's disease].

Spottke A, Schneider F, Dodel R.

Z Evid Fortbild Qual Gesundhwes. 2011;105(5):383-8. doi: 10.1016/j.zefq.2011.05.015. Epub 2011 Jun 16. German.

PMID:
21767798
16.

Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R.

Neurodegener Dis. 2011;8(6):438-46. doi: 10.1159/000325829. Epub 2011 May 12.

PMID:
21576919
17.

Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Paus S, Gross J, Moll-Müller M, Hentschel F, Spottke A, Wabbels B, Klockgether T, Abele M.

J Neurol. 2011 Oct;258(10):1835-40. doi: 10.1007/s00415-011-6029-6. Epub 2011 Apr 16.

PMID:
21499724
18.

Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE.

J Neurol. 2011 Oct;258(10):1827-34. doi: 10.1007/s00415-011-6028-7. Epub 2011 Apr 10.

PMID:
21479850
19.

Role of dysphagia in evaluating Parkinson patients for subthalamic nucleus stimulation: a case report.

Allert N, Kelm D, Spottke A, Coenen VA.

J Neural Transm (Vienna). 2011 Sep;118(9):1345-8. doi: 10.1007/s00702-011-0608-7. Epub 2011 Feb 27.

PMID:
21359972
20.

Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume.

Striepens N, Scheef L, Wind A, Meiberth D, Popp J, Spottke A, Kölsch H, Wagner M, Jessen F.

Psychol Med. 2011 Sep;41(9):1997-2006. doi: 10.1017/S0033291711000067. Epub 2011 Feb 2.

PMID:
21284913

Supplemental Content

Loading ...
Support Center